Website Metrics and Site Statistics by NextSTAT PCRM >> Good Medicine Magazine >> A Troubled History: Drugs that were safe in animal tests but later banned for human use >> Summer 2006
PCRM Home
Media CenterHealthResearchAbout PCRM CatalogJoin Us
PCRM Home
 

Action Alert: Urge the FDA to Implement Non-Animal Drug Tests



Summer 2006• Volume XV, Number 3

e-mail this page

A Troubled History

According to the FDA, 92 percent of drugs tested safe and effective in animals fail during human trials, and over half of the 8 percent gaining approval are later withdrawn or relabeled due to severe side effects. Among the drugs that were safe in animal tests but later banned for human use are the following.

Vioxx packVioxx:  The FDA’s Dr. David Graham called this cox-2 inhibitor (anti-inflammatory drug) “the single greatest drug-safety catastrophe in the history of the world.” During four and a half years on the market (until September 2004), it is estimated to have caused 140,000-160,000 serious cardiovascular events and 60,000-70,000 deaths in the U.S. alone. The worldwide estimates are 320,000 cardiovascular events and 140,000 deaths. Vioxx was not only safe but sometimes protective for cardiovascular risk in at least eight studies in six animal species.

Baycol:  A cholesterol-lowering drug approved in 1997, it was withdrawn in 2001 after causing over 100 deaths from rhabdomyolysis (muscle destruction). This adverse effect was not seen in preclinical tests in five animal species. After the drug was withdrawn, comparative studies showed that rat muscle cells were 200 times more resistant to the damaging effects of Baycol than human muscle cells.

Propulsid:  A heartburn drug often prescribed for GI reflux, Propulsid caused over 300 deaths between 1993 and its withdrawal in 2000. Many of the deaths were among infants and children. Along with the withdrawn allergy drugs Seldane (1992) and Hismanal (1999), Propulsid caused fatal heart rhythm abnormalities.

Rezulin:  This drug for diabetes mellitus showed heart toxicities but no liver toxicities in animal studies. Approved in 1997 after clinical trials showed no human heart toxicities, Rezulin was immediately linked to severe liver damage. It was relabelled four times before its withdrawal in 2000, after being linked to nearly 400 deaths and many more cases of liver failure. Animal tests were thus false negative for liver disease and false positive for heart disease.

 


Media Center | Health | Research | About PCRM | Catalog | Join Us | Search | Site Index | Home

The site does not provide medical or legal advice. This Web site is for information purposes only.
Full Disclaimer
| Privacy Policy